Abstract
There is no generally and widely accepted definition of fatigue. Despite its increasing importance and awareness, it remains a poorly defined construct that is predominantly found in MS, but also in other diseases such as tumors, strokes, or chronic inflammatory processes. The term most likely refers to “abnormal fatigability,” “abnormal exhaustion,” or “increased exhaustibility.” In any case, MS-related fatigue is quite different from the tiredness that healthy people report and that persons with MS themselves experienced before the onset of the disease: They complain of a lack of drive and energy that is exacerbated or persistent depending on mental and/or physical load and that may affect both, mental and physical performances. Often, fatigue is worsened by increased ambient or body temperature, whether due to heat, fever, or physical exertion (“Uhthoff phenomenon”). Not infrequently, both the quality of life and the ability to work and perform activities of daily living are impaired to such an extent that, particularly in a less adaptive working environment, early retirement is inevitable and those affected increasingly withdraw from social activities (Sterz et al. 2016). Despite the enormous impact on the individual patient, the causes of fatigue have not been conclusively clarified. The following chapter refers to own studies of the author on various etiological factors of MS-related fatigue and discusses them in the context of other studies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ayache SS, Chalah MA. Fatigue in multiple sclerosis - insights into evaluation and management. Neurophysiol Clin. 2017;47:139–71.
Bakshi R, Shaikh ZA, Miletich RS, et al. Fatigue in multiple sclerosis and its relationship to depression and neurologic disability. Mult Scler. 2000;6:181–5.
Bertoli M, Tecchio F. Fatigue in multiple sclerosis: does the functional or structural damage prevail? Mult Scler. 2020;26(14):1809–15.
Bertolone K, Coyle PK, Krupp LB, Doscher CA. Cytokine correlates of fatigue in multiple sclerosis. Neurology. 1993;43:A356. (Abstract)
von Bismarck O, Dankowski T, Ambrosius B, et al. Treatment choices and neuropsychological symptoms of a large cohort of early MS. Neurol Neuroimmunol Neuroinflamm. 2018;5:e446.
Capone F, Collorone S, Cortese R, Di LV, Moccia M. Fatigue in multiple sclerosis: the role of thalamus. Mult Scler. 2020;26:6–16.
Chalah MA, Ayache SS. Is there a link between inflammation and fatigue in multiple sclerosis? J Inflamm Res. 2018;11:253–64.
Chelmicka-Schorr E, Arnason BG. Nervous system-immune system interactions and their role in multiple sclerosis. Ann Neurol. 1994;36(Suppl):S29–32.
Chelmicka-Schorr E, Checinski M, Arnason BG. Chemical sympathectomy augments the severity of experimental allergic encephalomyelitis. J Neuroimmunol. 1988;17:347–50.
Claros-Salinas D, Dittmer N, Neumann M, et al. Induction of cognitive fatigue in MS patients through cognitive and physical load. Neuropsychol Rehabil. 2013;23:182–201.
Colosimo C, Millefiorini E, Grasso MG, et al. Fatigue in MS is associated with specific clinical features. Acta Neurol Scand. 1995;92:353–5.
DeLuca J, Johnson SK, Beldowicz D, Natelson BH. Neuropsychological impairments in chronic fatigue syndrome, multiple sclerosis, and depression. J Neurol Neurosurg Psychiatry. 1995;58:38–43.
Engel C, Greim B, Zettl UK. Fatigue zum Zeitpunkt der Diagnosestellung und im frühen Verlauf der Multiplen Sklerose. Akt Neurol. 2004;31(Suppl 1):S51–2. (Abstract).
Flachenecker P. Pathophysiologie und Abgrenzung zu anderen Symptomen und Erkrankungen. In: Penner IK, editor. Fatigue bei Multipler Sklerose. Bad Honnef: Hippocampus Verlag; 2009. p. 20–38.
Flachenecker P. Fatigue in bei Multipler Sklerose – pathophysiologische Aspekte und Abgrenzung zur Depression. Med Psychother. 2017;12:93–101.
Flachenecker P, Bihler I, Weber F, Gottschalk M, Toyka KV, Rieckmann P. Cytokine mRNA expression in patients with multiple sclerosis and fatigue. Mult Scler. 2004;10:165–9.
Flachenecker P, Eichstädt K, Berger K, Ellenberger D, Friede T, Haas J, Kleinschnitz C, Pöhlau D, Rienhoff O, Stahmann A, Zettl UK. Multiple Sklersoe in Deutschland – aktualisierte Auswertungen des MS-Registers der DMSG 2014-2018. Fortschr Neurol Psychiatr. 2020;88(7):436–50.
Flachenecker P, König H, Meissner H, Müller G, Rieckmann P. Fatigue bei Multipler Sklerose. Valdierung des “Würzburger Erschöpfungs-Inventars bei Multipler Sklerose (WEIMuS)”. Neurol Rehabil. 2008;14:299–306.
Flachenecker P, Kos D. Fatigue. In: HSenze T, editor. Recommendations on rehabilitation services for persons with multiple sclerosis in Europe. Brussels: Rehabilitation in Multiple Sclerosis (RIMS); 2011. p. 18–9.
Flachenecker P, Kümpfel T, Kallmann B, et al. Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters. Mult Scler. 2002;8:523–6.
Flachenecker P, Meissner H. Fatigue in multiple sclerosis presenting as acute relapse: subjective and objective assessment. Mult Scler. 2008;14:274–7.
Flachenecker P, Meissner H. Fatigue bei Multipler Sklerose – wie diagnostizieren, wie behandeln? Neurol Rehabil. 2014;20:273–81.
Flachenecker P, Rieckmann P, Toyka KV, Jung S. Correlation of sICAM-1 and serum catecholamines in multiple sclerosis depends on clinical activity and disease course. J Neurol. 2001;248(suppl 2):II/176. (Abstract)
Flachenecker P, Rufer A, Bihler I, et al. Fatigue in MS is related to sympathetic vasomotor dysfunction. Neurology. 2003;61:851–4.
Flachenecker P, Wolf A, Krauser M, Hartung HP, Reiners K. Cardiovascular autonomic dysfunction in multiple sclerosis: correlation with orthostatic intolerance. J Neurol. 1999;246:578–86.
Genova HM, Rajagopalan V, DeLuca J, et al. Examination of cognitive fatigue in multiple sclerosis using functional magnetic resonance imaging and diffusion tensor imaging. PLoS One. 2013;8:e78811.
Ghajarzadeh M, Jalilian R, Eskandari G, Sahraian MA, Azimi A, Mohammadifar M. Fatigue in multiple sclerosis: relationship with disease duration, physical disability, disease pattern, age and sex. Acta Neurol Belg. 2013;113:411–4.
Giovannoni G, Thompson AJ, Miller DH, Thompson EJ. Fatigue is not associated with raised inflammatory markers in multiple sclerosis. Neurology. 2001;57:676–81.
Gottschalk M, Kümpfel T, Flachenecker P, et al. Fatigue and regulation of the hypothalamo-pituitary-adrenal axis in multiple sclerosis. Arch Neurol. 2005;62:277–80.
Hanken K, Eling P, Hildebrandt H. Is there a cognitive signature for MS-related fatigue? Mult Scler. 2015;21:376–81.
Heesen C, Gold SM, Raji A, Wiedemann K, Schulz KH. Cognitive impairment correlates with hypothalamo-pituitary-adrenal axis dysregulation in multiple sclerosis. Psychoneuroendocrinology. 2002;27:505–17.
Heesen C, Koehler G, Gross R, Tessmer W, Schulz KH, Gold SM. Altered cytokine responses to cognitive stress in multiple sclerosis patients with fatigue. Mult Scler. 2005;11:51–7.
Heesen C, Nawrath L, Reich C, Bauer N, Schulz KH, Gold SM. Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour? J Neurol Neurosurg Psychiatry. 2006;77:34–9.
Iriarte J, Subira ML, Castro P. Modalities of fatigue in multiple sclerosis: correlation with clinical and biological factors. Mult Scler. 2000;6:124–30.
Karaszewski JW, Reder AT, Anlar B, Arnason BG. Increased high affinity beta-adrenergic receptor densities and cyclic AMP responses of CD8 cells in multiple sclerosis. J Neuroimmunol. 1993;43:1–7.
Karaszewski JW, Reder AT, Anlar B, Kim WC, Arnason BG. Increased lymphocyte beta-adrenergic receptor density in progressive multiple sclerosis is specific for the CD8+, CD28-suppressor cell. Ann Neurol. 1991;30:42–7.
Kluger BM, Krupp LB, Enoka RM. Fatigue and fatigability in neurologic illnesses: proposal for a unified taxonomy. Neurology. 2013;80:409–16.
Kobelt G, Hou Q, Dong S, Jomaa K, Flachenecker P (2020) The effect of self-assessed fatigue and cognitive impairment on health care consumption, work capacity and utility: a study in 5475 patients in Germany. Eur J Neurol EPR2125 (Abstract).
Kos D, Kerckhofs E, Nagels G, D’Hooghe MB, Ilsbroukx S. Origin of fatigue in multiple sclerosis: review of the literature. Neurorehabil Neural Repair. 2008;22:91–100.
Kroencke DC, Lynch SG, Denney DR. Fatigue in multiple sclerosis: relationship to depression, disability, and disease pattern. Mult Scler. 2000;6:131–6.
Langeskov-Christensen M, Bisson EJ, Finlayson ML, Dalgas U. Potential pathophysiological pathways that can explain the positive effects of exercise on fatigue in multiple sclerosis: a scoping review. J Neurol Sci. 2017;373:307–20.
Lebre AT, Mendes MF, Tilbery CP, Almeida AL, Scatolini NA. Relation between fatigue and autonomic disturbances in multiple sclerosis. Arq Neuropsiquiatr. 2007;65:663–8.
Loy BD, Taylor RL, Fling BW, Horak FB. Relationship between perceived fatigue and performance fatigability in people with multiple sclerosis: a systematic review and meta-analysis. J Psychosom Res. 2017;100:1–7.
Manjaly ZM, Harrison NA, Critchley HD, et al. Pathophysiological and cognitive mechanisms of fatigue in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2019;90:642–51.
Meissner H, Pfitzner A, Zettl UK, Flachenecker P. Fatigue in multiple sclerosis: correlation to intensity of attention during inpatient rehabilitation. Mult Scler. 2009;15:S226. (Abstract)
Meissner H, Volkert J, König H, Alpers G, Flachenecker P. Fatigue in multiple sclerosis: subjective complaints and intensity of attention. Mult Scler. 2007;13(suppl 2):S228. (Abstract)
Neumann M, Sterr A, Claros-Salinas D, Gutler R, Ulrich R, Dettmers C. Modulation of alertness by sustained cognitive demand in MS as surrogate measure of fatigue and fatigability. J Neurol Sci. 2014;340:178–82.
Palotai M, Guttmann CR. Brain anatomical correlates of fatigue in multiple sclerosis. Mult Scler. 2020;26(7):751–64.
Patejdl R, Penner IK, Noack TK, Zettl UK. Multiple sclerosis and fatigue: a review on the contribution of inflammation and immune-mediated neurodegeneration. Autoimmune Rev. 2016;15:210–20.
Penner IK, Paul F. Fatigue as a symptom or comorbidity of neurological diseases. Nat Rev Neurol. 2017;13:662–75.
Pereira GM, Soares NM, Souza AR, Becker J, Finkelsztejn A, Almeida RMM. Basal cortisol levels and the relationship with clinical symptoms in multiple sclerosis: a systematic review. Arq Neuropsiquiatr. 2018;76:622–34.
Pfitzner A, Flachenecker P, Zettl UK. Effekte eines Ausdauertrainings unter normobaren Hypoxiebedingungen auf die Mobilität bei Patienten mit Multipler Sklerose: Ergebnisse einer randomisierten, prospektiven Studie. Neurol Rehabil. 2014;20:265–72.
Rudick RA, Barna BP. Serum interleukin 2 and soluble interleukin 2 receptor in patients with multiple sclerosis who are experiencing severe fatigue. Arch Neurol. 1990;47:254–5.
Sakakibara R, Mori M, Fukutake T, Kita K, Hattori T. Orthostatic hypotension in a case with multiple sclerosis. Clin Auton Res. 1997;7:163–5.
Schreiber H, Kiltz K, Lang M, et al. Fatigue, Kognition und Persönlichkeit bei Patienten mit RRMS. Eine Multizenterstudie. Nervenarzt. 2010;81(Suppl 1):39–40. (Abstract)
Schreiber H, Lang M, Kiltz K, Lang C. Is personality profile a relevant determinant of fatigue in multiple sclerosis? Front Neurol. 2015;6:2.
Sehle A, Vieten M, Mundermann A, Dettmers C. Difference in motor fatigue between patients with stroke and patients with multiple sclerosis: a pilot study. Front Neurol. 2014;5:279.
Shannon JR, Flattem NL, Jordan J, et al. Orthostatic intolerance and tachycardia associated with norepinephrine transporter deficiency. N Engl J Med. 2000;342:541–9.
Sheng WS, Hu S, Lamkin A, Peterson PK, Chao CC. Susceptibility to immunologically mediated fatigue in C57/BL/6 versus Balb/c mice. Clin Immunol Immunopathol. 1996;81:161–7.
Simpson S Jr, Tan H, Otahal P, et al. Anxiety, depression and fatigue at 5-year review following CNS demyelination. Acta Neurol Scand. 2016;134:403–13.
Sterz C, Ellenberger D, Friede T, Flachenecker P. Employment-associated factors in multiple sclerosis - results of a cross-sectional study in Germany. Edorium J Disabil Rehabil. 2016;2:24–33.
Stuke K, Flachenecker P, Zettl UK, et al. Symptomatology of MS: results from the German MS registry. J Neurol. 2009;256:1932–5.
Then Bergh F, Kümpfel T, Trenkwalder C, Rupprecht R, Holsboer F. Dysregulation of the hypothalamo-pituitary-adrenal axis is related to the clinical course of MS. Neurology. 1999;53:772–7.
Weinges-Evers N, Brandt AU, Bock M, et al. Correlation of self-assessed fatigue and alertness in multiple sclerosis. Mult Scler. 2010;16:1134–40.
Wiegmann K, Muthyala S, Kim DH, Arnason BG, Chelmicka Schorr E. Beta-adrenergic agonists suppress chronic/relapsing experimental allergic encephalomyelitis (CREAE) in Lewis rats. J Neuroimmunol. 1995;56:201–6.
Zoukos Y, Thomaides T, Mathias CJ, Cuzner ML. High beta-adrenoceptor density on peripheral blood mononuclear cells in progressive multiple sclerosis: a manifestation of autonomic dysfunction? Acta Neurol Scand. 1994;90:382–7.
Zoukos Y, Thomaides TN, Kidd D, Cuzner ML, Thompson A. Expression of β2 adrenoceptors on peripheral blood mononuclear cells in patients with primary and secondary progressive multiple sclerosis: a longitudinal six month study. J Neurol Neurosurg Psychiatry. 2003;74:197–202.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Flachenecker, P. (2023). Definitions, Epidemiology, and Etiological Factors. In: Penner, IK. (eds) Fatigue in Multiple Sclerosis. Springer, Cham. https://doi.org/10.1007/978-3-031-13498-2_2
Download citation
DOI: https://doi.org/10.1007/978-3-031-13498-2_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-13497-5
Online ISBN: 978-3-031-13498-2
eBook Packages: Behavioral Science and PsychologyBehavioral Science and Psychology (R0)